Flagship Principal and Chief Innovation Officer of Empress Therapeutics reads essay Genetic Chemistry: Expanding the Central Dogma of Biology, co-authored by Sabrina Yang & Jason Park.

Read the full essay here: https://www.flagshippioneering.com/stories/genetic-chemistry-expanding-the-central-dogma-of-biology

Genetic Chemistry: Expanding the Central Dogma of Biology

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, Moderna , Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics.